Drugs / Androderm® 2.5mg
last change Feb 2009 re-read 3 minutes ago

Androderm® 2.5mg

Developed for
prostate cancer
Investigated by
University of Chicago

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01187485 Jun 2004 → Feb 2008 prostate cancer University of Chicago Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Androderm 2.5mg ClinicalTrials.gov intervention name — accepted as the source's own label NCT01187485 ↗